Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 2
1954 2
1956 1
1957 1
1958 2
1959 1
1960 2
1961 5
1962 4
1963 4
1964 2
1965 4
1966 1
1967 1
1970 1
1972 4
1973 10
1974 7
1976 7
1977 5
1978 8
1979 4
1980 4
1981 7
1982 3
1983 7
1984 5
1985 4
1986 3
1987 3
1988 2
1989 9
1990 5
1991 8
1992 3
1993 5
1994 8
1995 3
1996 12
1997 17
1998 9
1999 7
2000 11
2001 13
2002 12
2003 15
2004 13
2005 8
2006 12
2007 15
2008 13
2009 14
2010 14
2011 21
2012 17
2013 24
2014 22
2015 24
2016 21
2017 25
2018 28
2019 26
2020 32
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

552 results
Results by year
Filters applied: . Clear all
Page 1
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.
Solomon BJ, Besse B, Bauer TM, Felip E, Soo RA, Camidge DR, Chiari R, Bearz A, Lin CC, Gadgeel SM, Riely GJ, Tan EH, Seto T, James LP, Clancy JS, Abbattista A, Martini JF, Chen J, Peltz G, Thurm H, Ou SI, Shaw AT. Solomon BJ, et al. Among authors: clancy js. Lancet Oncol. 2018 Dec;19(12):1654-1667. doi: 10.1016/S1470-2045(18)30649-1. Epub 2018 Nov 6. Lancet Oncol. 2018. PMID: 30413378 Clinical Trial.
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
Shaw AT, Solomon BJ, Besse B, Bauer TM, Lin CC, Soo RA, Riely GJ, Ou SI, Clancy JS, Li S, Abbattista A, Thurm H, Satouchi M, Camidge DR, Kao S, Chiari R, Gadgeel SM, Felip E, Martini JF. Shaw AT, et al. Among authors: clancy js. J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. J Clin Oncol. 2019. PMID: 30892989 Free PMC article. Clinical Trial.
CFTR modulator theratyping: Current status, gaps and future directions.
Clancy JP, Cotton CU, Donaldson SH, Solomon GM, VanDevanter DR, Boyle MP, Gentzsch M, Nick JA, Illek B, Wallenburg JC, Sorscher EJ, Amaral MD, Beekman JM, Naren AP, Bridges RJ, Thomas PJ, Cutting G, Rowe S, Durmowicz AG, Mense M, Boeck KD, Skach W, Penland C, Joseloff E, Bihler H, Mahoney J, Borowitz D, Tuggle KL. Clancy JP, et al. J Cyst Fibros. 2019 Jan;18(1):22-34. doi: 10.1016/j.jcf.2018.05.004. Epub 2018 Jun 20. J Cyst Fibros. 2019. PMID: 29934203 Free PMC article. Review.
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial.
Shaw AT, Solomon BJ, Chiari R, Riely GJ, Besse B, Soo RA, Kao S, Lin CC, Bauer TM, Clancy JS, Thurm H, Martini JF, Peltz G, Abbattista A, Li S, Ou SI. Shaw AT, et al. Among authors: clancy js. Lancet Oncol. 2019 Dec;20(12):1691-1701. doi: 10.1016/S1470-2045(19)30655-2. Epub 2019 Oct 25. Lancet Oncol. 2019. PMID: 31669155 Clinical Trial.
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.
Shaw AT, Felip E, Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Shaw AT, et al. Among authors: clancy js. Lancet Oncol. 2017 Dec;18(12):1590-1599. doi: 10.1016/S1470-2045(17)30680-0. Epub 2017 Oct 23. Lancet Oncol. 2017. PMID: 29074098 Free PMC article. Clinical Trial.
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, Parsonnet J, Patton KK, Rozner MA, Selzman KA, Shoda M, Srivathsan K, Strathmore NF, Swerdlow CD, Tompkins C, Wazni O. Kusumoto FM, et al. Among authors: clancy j. Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15. Heart Rhythm. 2017. PMID: 28919379 Review. No abstract available.
Biology and biogenesis of shed microvesicles.
Tricarico C, Clancy J, D'Souza-Schorey C. Tricarico C, et al. Among authors: clancy j. Small GTPases. 2017 Oct 2;8(4):220-232. doi: 10.1080/21541248.2016.1215283. Epub 2016 Aug 5. Small GTPases. 2017. PMID: 27494381 Free PMC article. Review.
Addendum: Kong, M.Y.; Whitley, R.J.; Peng, N.; Oster, R.; Schoeb, T.R.; Sullender, W.; Ambalavanan, N.; Clancy, J.P.; Gaggar, A.; Blalock J.E. Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses 2015, 30, 7, 4230–4253.
Kong MY, Whitley RJ, Peng N, Oster R, Schoeb TR, Sullender W, Ambalavanan N, Clancy JP, Gaggar A, Blalock JE. Kong MY, et al. Among authors: clancy jp. Viruses. 2015 Oct;7(10):5609. doi: 10.3390/v7102889. Viruses. 2015. PMID: 26702463 Free PMC article. No abstract available.
Advancing Integrated Care through Practice Coaching.
Henwood BF, Siantz E, Center K, Bataille G, Pomerance E, Clancy J, Gilmer TP. Henwood BF, et al. Among authors: clancy j. Int J Integr Care. 2020 Jun 26;20(2):15. doi: 10.5334/ijic.4737. Int J Integr Care. 2020. PMID: 32607102 Free PMC article.
552 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page